Making 15O-water Practically Available
MedTrace Pharma is a development stage company working on an automated system for production, injection and analysis of 15O-water PET.
Based in Denmark, Sweden and the US, we are preparing for the FDA phase III trial (cardiac application) and are in close collaboration with hospitals in the US, Europe and Japan.
Our solution consists of 1) the MT-100, which is a point-of-care GMP-compliant chemistry lab combining the process of manufacturing and injecting 15O-water into the patient and 2) the analytical software platform aQuant, that produces unprecedented images combined with quantitative data of the PET scan.
A double MPI test (rest and stress protocols) can be completed in less than 30 minutes.
Visit our booth at the Small Business Pavilion to learn more about our solution and collaboration opportunities.
Brands: MedTrace Pharma, MT-100, aQuant